This site uses cookies. By using this site you agree to receiving cookies. View Policy.

114%

Bluephage's, patented, microbiological testing kits developed at University of Barcelona, easily detect Coliphages in water (newly recognized as viral indicators of un-safe water). Distributing to 15 countries globally, Bluephage are well placed to enter the €1.4 billion (2022) water testing market.

  • Bluephage is the 1st water biotech company in Spain to become a B-Corp
  • Commercializing patented technology, licensed to us by University of Barcelona 
  • Our coliphage, water testing kits help prevent water-borne diseases
  • Distributing to 12 EU countries, Singapore, South Africa & Georgia

Idea

Bluephage was founded in 2016 as a spin-off from the University of Barcelona by renowned researchers from the Health-Related Water Microbiology Research Group (MARS).

Our goal is to help fight the global water crisis & becoming a B-Corp only helped to reinforce this.

In 2021, the European Commission recognized Coliphages as a new, viral indicator within water. Water free of Coliphages generally can be deemed safe. With this patented, disruptive technology, licensed to us by University of Barcelona, you can detect Coliphages in just 6hrs. This is critical in a global context where rapid testing can help save lives, and where water safety is a key driver of policy making.

Over the last year we've gone from focusing on R&D to commercializing a product that quickly tests water for Coliphages. We've raised over €1.3m through two private rounds and several public grants. We're expanding our distributor network internationally with a presence currently in 12 European countries, Singapore, South Africa, & Georgia. Further, Our work in this area has already been recognized by Water Europe, who awarded us their '2020 SME Innovation Award'.

We're now ready to launch the 'Rapid Kit' to wider markets and hope that the Crowdcube community will help us in distributing this technology to ensure safe water for a better world.

For everyone, for the planet, help us fight the water crisis!

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Bluephage pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investing in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. You will only be able to invest via Crowdcube once you are registered as sufficiently sophisticated. Please click here to read the full Risk Warning.

Crowdcube is authorised and regulated by the Financial Conduct Authority (FCA) and the Comisión Nacional del Mercado de Valores (CNMV). This page has been approved by Crowdcube. Pitches for investment are not offers to the public and investments can only be made by members of crowdcube.com on the basis of information provided in the pitches by the companies concerned. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.